The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Narcolepsy Treatment-Global Market Insights and Sales Trends 2024
Synopsis
Narcolepsy is a chronic neurological disorder that is associated with Excessive Daytime Sleepiness (EDS), hypnagogic hallucinations, cataplexy, sleep paralysis, and fragmented night sleep.
The global Narcolepsy Treatment market size is expected to reach US$ 3291.2 million by 2029, growing at a CAGR of 2.5% from 2023 to 2029. The market is mainly driven by the significant applications of Narcolepsy Treatment in various end use industries. The expanding demands from the Primary Narcolepsy with Cataplexy, Primary Narcolepsy without Cataplexy, Narcolepsy Due to Medical Conditions and Unspecified Narcolepsy, are propelling Narcolepsy Treatment market. Sodium Oxybate, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Antidepressants segment is estimated at % CAGR for the next seven-year period.
By therapeutic treatment, the global narcolepsy treatment market is segmented into central nervous system stimulants, sodium oxybate, and antidepressants.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Narcolepsy Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Narcolepsy Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Narcolepsy Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Narcolepsy Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Narcolepsy Treatment covered in this report include Teva Pharmaceutical, Takeda, Jazz Pharmaceuticals, Arena Pharmaceuticals, Graymark Healthcare and Ligand Pharmaceuticals, etc.
The global Narcolepsy Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Teva Pharmaceutical
Takeda
Jazz Pharmaceuticals
Arena Pharmaceuticals
Graymark Healthcare
Ligand Pharmaceuticals
Global Narcolepsy Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Narcolepsy Treatment market, Segment by Type:
Sodium Oxybate
Antidepressants
Central Nervous System Stimulants
Others
Global Narcolepsy Treatment market, by Application
Primary Narcolepsy with Cataplexy
Primary Narcolepsy without Cataplexy
Narcolepsy Due to Medical Conditions
Unspecified Narcolepsy
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Narcolepsy Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Narcolepsy is a chronic neurological disorder that is associated with Excessive Daytime Sleepiness (EDS), hypnagogic hallucinations, cataplexy, sleep paralysis, and fragmented night sleep.
The global Narcolepsy Treatment market size is expected to reach US$ 3291.2 million by 2029, growing at a CAGR of 2.5% from 2023 to 2029. The market is mainly driven by the significant applications of Narcolepsy Treatment in various end use industries. The expanding demands from the Primary Narcolepsy with Cataplexy, Primary Narcolepsy without Cataplexy, Narcolepsy Due to Medical Conditions and Unspecified Narcolepsy, are propelling Narcolepsy Treatment market. Sodium Oxybate, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Antidepressants segment is estimated at % CAGR for the next seven-year period.
By therapeutic treatment, the global narcolepsy treatment market is segmented into central nervous system stimulants, sodium oxybate, and antidepressants.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Narcolepsy Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Narcolepsy Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Narcolepsy Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Narcolepsy Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Narcolepsy Treatment covered in this report include Teva Pharmaceutical, Takeda, Jazz Pharmaceuticals, Arena Pharmaceuticals, Graymark Healthcare and Ligand Pharmaceuticals, etc.
The global Narcolepsy Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Teva Pharmaceutical
Takeda
Jazz Pharmaceuticals
Arena Pharmaceuticals
Graymark Healthcare
Ligand Pharmaceuticals
Global Narcolepsy Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Narcolepsy Treatment market, Segment by Type:
Sodium Oxybate
Antidepressants
Central Nervous System Stimulants
Others
Global Narcolepsy Treatment market, by Application
Primary Narcolepsy with Cataplexy
Primary Narcolepsy without Cataplexy
Narcolepsy Due to Medical Conditions
Unspecified Narcolepsy
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Narcolepsy Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Narcolepsy Treatment
1.1 Narcolepsy Treatment Market Overview
1.1.1 Narcolepsy Treatment Product Scope
1.1.2 Narcolepsy Treatment Market Status and Outlook
1.2 Global Narcolepsy Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Narcolepsy Treatment Market Size by Region (2018-2029)
1.4 Global Narcolepsy Treatment Historic Market Size by Region (2018-2023)
1.5 Global Narcolepsy Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Narcolepsy Treatment Market Size (2018-2029)
1.6.1 North America Narcolepsy Treatment Market Size (2018-2029)
1.6.2 Europe Narcolepsy Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Narcolepsy Treatment Market Size (2018-2029)
1.6.4 Latin America Narcolepsy Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Narcolepsy Treatment Market Size (2018-2029)
2 Narcolepsy Treatment Market by Type
2.1 Introduction
2.1.1 Sodium Oxybate
2.1.2 Antidepressants
2.1.3 Central Nervous System Stimulants
2.1.4 Others
2.2 Global Narcolepsy Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Narcolepsy Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Narcolepsy Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Narcolepsy Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Narcolepsy Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Narcolepsy Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Narcolepsy Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Narcolepsy Treatment Revenue Breakdown by Type (2018-2029)
3 Narcolepsy Treatment Market Overview by Application
3.1 Introduction
3.1.1 Primary Narcolepsy with Cataplexy
3.1.2 Primary Narcolepsy without Cataplexy
3.1.3 Narcolepsy Due to Medical Conditions
3.1.4 Unspecified Narcolepsy
3.2 Global Narcolepsy Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Narcolepsy Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Narcolepsy Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Narcolepsy Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Narcolepsy Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Narcolepsy Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Narcolepsy Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Narcolepsy Treatment Revenue Breakdown by Application (2018-2029)
4 Narcolepsy Treatment Competition Analysis by Players
4.1 Global Narcolepsy Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Narcolepsy Treatment as of 2022)
4.3 Date of Key Players Enter into Narcolepsy Treatment Market
4.4 Global Top Players Narcolepsy Treatment Headquarters and Area Served
4.5 Key Players Narcolepsy Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Narcolepsy Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Teva Pharmaceutical
5.1.1 Teva Pharmaceutical Profile
5.1.2 Teva Pharmaceutical Main Business
5.1.3 Teva Pharmaceutical Narcolepsy Treatment Products, Services and Solutions
5.1.4 Teva Pharmaceutical Narcolepsy Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Teva Pharmaceutical Recent Developments
5.2 Takeda
5.2.1 Takeda Profile
5.2.2 Takeda Main Business
5.2.3 Takeda Narcolepsy Treatment Products, Services and Solutions
5.2.4 Takeda Narcolepsy Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Takeda Recent Developments
5.3 Jazz Pharmaceuticals
5.3.1 Jazz Pharmaceuticals Profile
5.3.2 Jazz Pharmaceuticals Main Business
5.3.3 Jazz Pharmaceuticals Narcolepsy Treatment Products, Services and Solutions
5.3.4 Jazz Pharmaceuticals Narcolepsy Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Arena Pharmaceuticals Recent Developments
5.4 Arena Pharmaceuticals
5.4.1 Arena Pharmaceuticals Profile
5.4.2 Arena Pharmaceuticals Main Business
5.4.3 Arena Pharmaceuticals Narcolepsy Treatment Products, Services and Solutions
5.4.4 Arena Pharmaceuticals Narcolepsy Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Arena Pharmaceuticals Recent Developments
5.5 Graymark Healthcare
5.5.1 Graymark Healthcare Profile
5.5.2 Graymark Healthcare Main Business
5.5.3 Graymark Healthcare Narcolepsy Treatment Products, Services and Solutions
5.5.4 Graymark Healthcare Narcolepsy Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Graymark Healthcare Recent Developments
5.6 Ligand Pharmaceuticals
5.6.1 Ligand Pharmaceuticals Profile
5.6.2 Ligand Pharmaceuticals Main Business
5.6.3 Ligand Pharmaceuticals Narcolepsy Treatment Products, Services and Solutions
5.6.4 Ligand Pharmaceuticals Narcolepsy Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Ligand Pharmaceuticals Recent Developments
6 North America
6.1 North America Narcolepsy Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Narcolepsy Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Narcolepsy Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Narcolepsy Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Narcolepsy Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Narcolepsy Treatment Market Dynamics
11.1 Narcolepsy Treatment Industry Trends
11.2 Narcolepsy Treatment Market Drivers
11.3 Narcolepsy Treatment Market Challenges
11.4 Narcolepsy Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
